Burney CO Astrazeneca PLC Transaction History

Burney CO

$2.4 Billion
Q1 2025

A detailed history of Burney CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Burney CO holds 15,972 shares of AZN stock, worth $1.12 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

15,972

Previous 15,891 0.51%

Holding current value

$1.12 Million

Previous $1.04 Million 12.68%

% of portfolio

0.05%

Previous 0.04%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$65.37 - $77.96 $5,294 - $6,314	81 Added 0.51%	15,972 $1.17 Million
Q4 2024 Jan 14, 2025	BUY	$63.2 - $79.58 $55,110 - $69,393	872 Added 5.81%	15,891 $1.04 Million
Q3 2024 Oct 18, 2024	SELL	$76.67 - $87.62 $208,695 - $238,501	-2,722 Reduced 15.34%	15,019 $1.17 Million
Q2 2024 Jul 29, 2024	SELL	$66.81 - $80.83 $30,398 - $36,777	-455 Reduced 2.5%	17,741 $1.38 Million
Q1 2024 May 22, 2024	SELL	$61.03 - $69.57 $42,354 - $48,281	-694 Reduced 3.67%	18,196 $1.23 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $307,345 - $344,044	-4,966 Reduced 20.82%	18,890 $1.27 Million
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $103,565 - $114,504	1,597 Added 7.17%	23,856 $1.62 Million
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $47,329 - $51,323	677 Added 3.14%	22,259 $1.59 Million
Q1 2023 May 10, 2023	SELL	$63.15 - $71.6 $83,358 - $94,511	-1,320 Reduced 5.76%	21,582 $1.5 Million
Q4 2022 Feb 06, 2023	SELL	$54.21 - $70.44 $24,936 - $32,402	-460 Reduced 1.97%	22,902 $1.55 Million
Q3 2022 Nov 15, 2022	BUY	$53.02 - $135.75 $11,187 - $28,643	211 Added 0.91%	23,362 $1.28 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $1,362 - $1,636	23 Added 0.1%	23,151 $1.53 Million
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $164,262 - $197,869	-2,948 Reduced 11.31%	23,128 $1.53 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $102,259 - $120,830	-1,893 Reduced 6.77%	26,076 $1.52 Million
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $59,838 - $65,470	-1,077 Reduced 3.71%	27,969 $1.68 Million
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $115,965 - $144,131	-2,395 Reduced 7.62%	29,046 $1.74 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $216,700 - $250,151	-4,595 Reduced 12.75%	31,441 $1.56 Million
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $168,461 - $201,445	-3,472 Reduced 8.79%	36,036 $1.8 Million
Q3 2020 Dec 14, 2020	SELL	$53.07 - $61.1 $20,591 - $23,706	-388 Reduced 0.97%	39,508 $2.17 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $116,757 - $149,834	-2,709 Reduced 6.36%	39,896 $2.11 Million
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $220,806 - $299,921	-5,843 Reduced 12.06%	42,605 $1.9 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $252,637 - $300,237	-5,950 Reduced 10.94%	48,448 $2.42 Million
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $685,490 - $776,900	-17,086 Reduced 23.9%	54,398 $2.43 Million
Q2 2019 Aug 12, 2019	SELL	$37.28 - $41.68 $364,784 - $407,838	-9,785 Reduced 12.04%	71,484 $2.95 Million
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $397,026 - $481,264	-11,187 Reduced 12.1%	81,269 $3.29 Million
Q4 2018 Feb 12, 2019	SELL	$36.86 - $41.49 $77,590 - $87,336	-2,105 Reduced 2.23%	92,456 $3.51 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $358,445 - $409,592	-10,312 Reduced 9.83%	94,561 $3.74 Million
Q2 2018 Aug 13, 2018	SELL	$34.55 - $37.05 $17,862 - $19,154	-517 Reduced 0.49%	104,873 $3.68 Million
Q1 2018 May 08, 2018	SELL	$32.97 - $36.63 $151,826 - $168,681	-4,605 Reduced 4.19%	105,390 $3.69 Million
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $213,173 - $231,043	6,643 Added 6.43%	109,995 $3.82 Million
Q3 2017 Nov 13, 2017	SELL	$28.96 - $34.0 $140,890 - $165,410	-4,865 Reduced 4.5%	103,352 $3.46 Million
Q3 2017 Nov 09, 2017	BUY	$28.96 - $34.0 $3.13 Million - $3.68 Million	108,217	108,217 $3.69 Million

Others Institutions Holding AZN

# of Institutions

1,427

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account